Trial intelligence / Profile preview

N-Acetylcysteine Inhalation in Critically Ill Mechanically Ventilated Patients

NCT07409727Phase 4Recruiting

Sponsor
Cairo University
Start
Mar 2026
Primary completion
Mar 2028
Countries
1
01

Overview

A Phase 4 trial of acetylcysteine inhalation solution in ventilator-associated pneumonia (VAP), sponsored by Cairo University. Started Mar 2026; status: recruiting.

02

Drugs

acetylcysteine inhalation solution
03

Conditions

ventilator-associated pneumonia (VAP)

Beyond the preview

Go deeper on NCT07409727.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07409727.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call